[38] It was a single center trial where participants received a permanent vena cava filter or no filter and were followed for 33 days. The main outcomes were mortality, PE and complications of ...

Optional vena cava filters can used to provide either short-term or permanent protection from pulmonary embolism. These devices have recently become available for clinical use in the United States.